Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. RYAM
RYAM logo

RYAM Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Rayonier Advanced Materials Inc (RYAM) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
7.360
1 Day change
-4.79%
52 Week Range
11.850
Analysis Updated At
2026/07/03
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

RYAM is not a good buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock is technically oversold, but the broader trend is still weak, there is no strong proprietary buy signal, no recent news catalyst, and the short-term pattern expectation remains negative. If the investor is impatient and wants to act now, this is still not an attractive long-term entry based on the current data.

Technical Analysis

Current price is 7.36 after a -4.79% move, with the market closed. RSI_6 is 16.0, which signals extreme oversold conditions, but MACD histogram is -0.0716 and still negatively expanding, showing downside momentum is not yet reversed. Moving averages are converging, which can hint at a possible inflection point, but the stock remains below the pivot at 8.18 and only slightly above S1 at 7.443, with S2 at 6.987 below. Overall trend: weak, oversold, but not confirmed for reversal. Similar candlestick pattern analysis suggests 2.35% upside next day, but -7.69% next week and -8.47% next month, which weakens the case for immediate buying.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Options sentiment is mildly bullish on open interest basis because the put-call ratio of 0.84 is below 1.0, suggesting slightly more call positioning than puts. However, option volume put-call ratio at 0.0 is not meaningful for balanced sentiment here because put volume is extremely low. Implied volatility is very high at 100.24 with IV percentile 95.62, indicating options are pricing in large expected movement. Call open interest (11,578) exceeds put open interest (9,739), and total trading volume is elevated versus averages, but the price action does not yet confirm a durable bullish setup.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
12
Buy
4

Positive Catalysts

  • ["RSI is deeply oversold, which can support a rebound attempt.", "Call open interest exceeds put open interest, showing a slight bullish tilt in positioning.", "High option activity and elevated implied volatility can create a sharp bounce if momentum shifts."]

Neutral/Negative Catalysts

  • ["No news in the recent week, so there is no event-driven catalyst.", "MACD remains negative and is still deteriorating, confirming weak momentum.", "The stock trend model projects weakness over the next week and month.", "No strong AI Stock Picker signal and no recent SwingMax signal.", "No significant hedge fund, insider, or congress trading support."]

Financial Performance

No usable financial snapshot was provided due to an error, so latest quarterly revenue and earnings growth cannot be verified. Because the latest quarter season is not available, there is no solid fundamental confirmation from the provided data to support a long-term buy decision.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating or price target trend data was provided. Based on the available information, Wall Street pros currently appear neutral to cautious: there is no visible upgrade cycle, no strong positive target revision trend, and no evidence of broad analyst enthusiasm from the data provided. The pros: oversold technical setup and mild options positioning support a potential rebound. The cons: weak momentum, no recent catalyst, no insider or institutional accumulation signal, and no analyst confirmation.

Wall Street analysts forecast RYAM stock price to rise
2 Analyst Rating
Wall Street analysts forecast RYAM stock price to rise
1 Buy
1 Hold
0 Sell
Moderate Buy
Current: 7.730
sliders
Low
9
Averages
9
High
9
Current: 7.730
sliders
Low
9
Averages
9
High
9
RBC Capital
Outperform
maintain
$9 -> $14
AI Analysis
2026-03-05
Reason
RBC Capital
Price Target
$9 -> $14
AI Analysis
2026-03-05
maintain
Outperform
Reason
RBC Capital raised the firm's price target on Rayonier Advanced Materials to $14 from $9 and keeps an Outperform rating on the shares. RBC is positive on the company's messaging with its results as reflecting a significant acceleration in the value-over-volume and repricing strategy that had begun to play out over the past few years, and believes the positive market response was directionally appropriate, the analyst tells investors in a research note.

People Also Watch